ENTITY

REGENXBIO Inc (RGNX US)

27
Analysis
Health CareUnited States
REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
Company Event25 Feb 2025 13:00 • Upcoming
Add To Calendar
Company Event07 Nov 2024 05:30 • Latest
Company Event02 Aug 2024 04:30
Company Event09 May 2024 04:30
Company Event05 Mar 2024 21:30
x